ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681637 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681637; 2) Community: the network communities that were significantly associated with the response to NSC 681637; 3) Molecule: the relationships between components within communities and NSC 681637; 4) MDR: the compounds that were significantly associated with the NSC 681637.

NSC Compound Enrichment Correlation
NSC 742544 Naphth[1',2':4,5]imidazo[1,2-a]pyridine-5,6-dione, 9-chloro- 0.00126952303154152 0.19075314
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0013187520236934 0.56510866
NSC 606172 Camptothecin Derivative 0.00131875202369342 0.86674425
NSC 677776 Null 0.00131875202369342 0.053384991
NSC 683557 Camptothecin Derivative 0.00166561193816139 0.8756825
NSC 72151 2H-1-Benzopyran-2-one, 6-[[4-[bis[2-[(methylsulfonyl)ethyl]amino]phenyl]methylene]amino]- (9CI) 0.00166561193816139 0.49180881
NSC 76356 Adenine, 9-.beta.-D-arabinofuranosyl-2-chloro- (8CI) 0.00166561193816139 0.5561532
NSC 623902 Null 0.0016656119381614 0.23569241
NSC 639366 1-[[3'-(Diethylamino)-2'-hydroxypropyl]amino]-4- [(2'',3''-epoxypropyl)-amino-9,10-anthracenedione Fumaric Acid 0.0016656119381614 0.41481602
NSC 681634 Camptothecin Derivative 0.0016656119381614 0.86777317
Total:72  Current:4    [First] [Prev] [Next] [Last]